Structure via PubChem · Public domain (PubChem)
7-ethyl-10-hydroxycamptothecin
Sign in to saveAlso known as SN 38 lactone, 10-Hydroxy-7-ethylcamptothecin, 7-Ethyl-10-hydroxy-20(S)-camptothecin, SN 38
SN-38 is an antineoplastic drug. It is the active metabolite of irinotecan (an analog of camptothecin - a topoisomerase I inhibitor) but has 1000 times more activity than irinotecan itself. In vitro cytotoxicity assays show that the potency of SN-38 relative to irinotecan varies from 2- to 2000-fold.
In the Vinony graph
Within Vinony's link graph, 7-ethyl-10-hydroxycamptothecin is referenced by 23 other articles, and connects out to UGT1A1, diarrhea and digital object identifier.
Vinony files it under ECHA InfoCard ID from Wikidata and Topoisomerase inhibitors.
Its subject is documented across 7 Wikipedia language editions.
Chemical data
- Formula
- C22H20N2O5
- Molecular weight
- 392.4 g/mol
- IUPAC name
- (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
- SMILES
- CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O
- InChIKey
- FJHBVJOVLFPMQE-QFIPXVFZSA-N
- XLogP
- 1.4
- Polar surface area
- 100 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
- Indications
- small cell lung carcinoma, breast cancer, lung cancer, cancer
via ChEMBL · EBI
Wikidata facts
- Subclass of
- alkaloid
- Mass
- 392.137222
Show 3 more facts
- chemical formula
- C₂₂H₂₀N₂O₅
- isomeric SMILES
- CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O
- canonical SMILES
- CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O
Sources (5)
via Wikidata · CC0
~2 min read
Encyclopedic overview
4 sectionsContents
- Use in antibody-drug conjugates
- Interactive pathway map
- See also
- References
SN-38 is an antineoplastic drug. It is the active metabolite of irinotecan (an analog of camptothecin - a topoisomerase I inhibitor) but has 1000 times more activity than irinotecan itself. In vitro cytotoxicity assays show that the potency of SN-38 relative to irinotecan varies from 2- to 2000-fold.
SN38 is formed via hydrolysis of irinotecan by carboxylesterases and metabolized via glucuronidation by UGT1A1.
Excerpted from Wikipedia’s “7-ethyl-10-hydroxycamptothecin” article, available under the CC BY-SA 4.0 licence.